These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Poxviral immunomodulatory proteins as new therapeutics for immunocorrection]. Nepomniashchikh TS; Shchelkunov SN Mol Biol (Mosk); 2008; 42(5):904-12. PubMed ID: 18988538 [TBL] [Abstract][Full Text] [Related]
24. beta-Glycosphingolipids as immune modulators. Adar T; Ilan Y J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392 [TBL] [Abstract][Full Text] [Related]
25. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases]. Szegedi G Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis). Pongratz D J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756 [TBL] [Abstract][Full Text] [Related]
27. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases]. Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605 [TBL] [Abstract][Full Text] [Related]
28. Inflammatory, immune, and viral aspects of inclusion-body myositis. Dalakas MC Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143 [TBL] [Abstract][Full Text] [Related]
30. The role of humoral autoimmunity in gastrointestinal neuromuscular diseases. Hubball A; Martin JE; Lang B; De Giorgio R; Knowles CH Prog Neurobiol; 2009 Jan; 87(1):10-20. PubMed ID: 18929621 [TBL] [Abstract][Full Text] [Related]
31. Understanding autoimmune disease: new targets for drug discovery. Balagué C; Kunkel SL; Godessart N Drug Discov Today; 2009 Oct; 14(19-20):926-34. PubMed ID: 19596080 [TBL] [Abstract][Full Text] [Related]
32. B lymphocytes are required for development and treatment of autoimmune diseases. Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517 [TBL] [Abstract][Full Text] [Related]
33. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases. Chin LT; Chu C; Chen HM; Wang DW; Liao SK Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049 [TBL] [Abstract][Full Text] [Related]